Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParkmead Regulatory News (PMG)

Share Price Information for Parkmead (PMG)

Share Price is delayed by 15 minutes
Get Live Data
18.50    0.00 (0.00%)
Bid:
18.00
Ask:
19.00
Spread: 1.00 (5.556%)
Market Cap: £20.21m
PMG Live PriceLast checked at - London Stock Exchange

Intraday Parkmead Share Chart

Disposal

8 Nov 2007 15:57

Parkmead Group (The) PLC08 November 2007 Thursday 8 November 2007 THE PARKMEAD GROUP PLC ("Parkmead" or the "Group") Sale of Quayside Corporate Services Limited ("Quayside") The Board of Parkmead (the "Board") is pleased to announce the sale of Quaysideto David Mills for an initial cash consideration of £0.63 million plus adeferred cash payment of up to £1.97 million payable by 8 November 2008. DavidMills is a former Director of Parkmead and a significant shareholder inParkmead, accordingly he is considered a related party for this transaction. Quayside provides turnaround consulting services to businesses which havedeveloped trading difficulties. The effect of this sale on Parkmead will meanthat the Group is now wholly focused on the energy sector. Proceeds from thesale will form part of the resources for making principal investments in energybased assets. The net assets of Quayside which are being disposed of as a part of thistransaction as at 30 June 2007 were (negative) £0.15 million. During the yearended 30 June 2007 Quayside reported a loss of £0.19 million. As at 30 June2007, the goodwill generated on the original acquisition of Quayside was valuedin the audited accounts of the Group at £2.68 million. In the PreliminaryResults announced on 27 September this year the unpredictable nature of thedistressed company debt markets in which Quayside operates was noted. Havingregard to this and the future prospects of Quayside the Board has concluded thatthe sale of Quayside is in the best interests of the Group and that theconsideration received is satisfactory. In order to satisfy the initial cash consideration Mr Mills has today agreed tosell a total of 12,611,009 Ordinary Shares in Parkmead at a price of 5p. Of the12,611,009 shares sold by Mr Mills 2,000,000 have been purchased by Mr ColinGoodall, 1,000,000 shares by Mr John Leggate, 4,000,000 by Mr Tom Cross and200,000 by Mr Gordon Ashworth who are each a Director of the Group. AdditionallyMr Iain Rawlinson, a Director of one of the Group's subsidiaries, Radius EnergyLimited, purchased 4,000,000 shares. Accordingly Mr Mills, Mr Goodall, MrLeggate, Mr Cross, Mr Rawlinson and Mr Ashworth now have the followingbeneficial interest in the Group: Number of Ordinary Shares % of existing Share Capital David Mills* 63,146,567 17.14%Tom Cross** 4,000,000 1.09%Iain Rawlinson*** 4,000,000 1.09%Colin Goodall** 2,000,000 0.54%John Leggate** 1,000,000 0.27%Gordon Ashworth** 200,000 0.05% * former director of the Group ** current director of the Group *** director of a subsidiary of the Group Mr Mills intends to satisfy the payment of the deferred consideration throughthe sale of further shares in the Group. In accordance with the AIM rules the Directors of the Group are satisfied,having consulted with Charles Stanley Securities, its nominated adviser, thatthe terms of the transaction are fair and reasonable insofar as its shareholdersare concerned. Commenting, Chairman, Colin Goodall, said: "We are delighted to have reached this agreement with David and would like totake the opportunity of wishing him every success in re positioning Quayside.The Group will now focus on the energy sector and I look forward to growth overthe coming year" -Ends- For further information: The Parkmead Group plc 020 7494 5770Niall Doran CEOGordon Ashworth, CFO Madano Partnership 0207 593 4000Mathew Moth Charles Stanley Securities (Nominated Adviser) 0207 149 6482Rick ThompsonHenry Fitzgerald-O'Connor This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
18th May 201010:00 amRNSFaroe Petroleum Rights Issue
10th Mar 20107:00 amRNSHalf Yearly Report
5th Feb 20107:00 amRNSChange of Registered Office
31st Dec 200912:24 pmRNSAGM Statement
24th Dec 200912:29 pmRNSNotification of Change in Directors Details
22nd Dec 200910:37 amRNSDirectorate Change
4th Dec 20097:00 amRNSPreliminary results
6th Nov 20098:01 amRNSHolding(s) in Company
4th Nov 20091:48 pmRNSTotal Voting Rights
2nd Nov 200911:52 amRNSResult of Meeting
12th Oct 20097:00 amRNSAcquisition
14th Sep 200910:57 amRNSHolding(s) in Company
22nd Jun 200912:10 pmRNSDirector/PDMR Shareholding
21st May 20093:53 pmRNSHolding(s) in Company
31st Mar 20097:00 amRNSInterim Results
3rd Dec 20084:20 pmRNSResult of AGM
21st Nov 200811:36 amRNSResult of EGM
10th Nov 20083:54 pmRNSAnnual Report and Accounts
6th Nov 20085:01 pmRNSReconvening of EGM
31st Oct 20081:53 pmRNSReconvening of EGM
27th Oct 200812:48 pmRNSResult of EGM
17th Oct 20087:53 amRNSFinal Results
3rd Oct 20083:21 pmRNSAdoption of new Articles of Association
15th Aug 20087:30 amRNSDirectorate Change
17th Jun 20087:00 amRNSStatement re Investment
16th Jun 200810:30 amRNSHolding(s) in Company
12th Jun 20087:05 amRNSHolding(s) in Company
12th Jun 20087:00 amRNSHolding(s) in Company
19th May 20087:00 amRNSCreation of Advisory Board an
11th Feb 200811:56 amRNSHolding(s) in Company
8th Feb 20087:00 amRNSInterim Results
21st Dec 20073:55 pmRNSResult of AGM
12th Dec 20074:21 pmRNSAcquisition-Amendment
6th Dec 20074:59 pmRNSAcquisition
30th Nov 20077:10 amRNSInvestment
30th Nov 20077:01 amRNSAudited Final Results
8th Nov 20073:57 pmRNSDisposal
27th Sep 20072:02 pmRNSFinal Results
15th Aug 20076:20 pmRNSAIM Rule 26 Information
10th Aug 20077:00 amRNSChange of Adviser
13th Jul 20074:02 pmRNSHolding(s) in Company
29th Jun 20078:00 amRNSDirectorate Change
4th Jun 200712:32 pmRNSHolding(s) in Company
21st Mar 20077:02 amRNSInterim Results
20th Feb 20077:00 amRNSDisposal
2nd Feb 20078:14 amRNSDisposal
15th Dec 20061:08 pmRNSTotal Voting Rights
11th Dec 20064:36 pmRNSAdditional Listing
19th Oct 20067:01 amRNSPreliminary Results
6th Oct 20061:32 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.